-
Mashup Score: 0Opinion | Why Is One Dose Suddenly Enough for the mRNA COVID Vaccines? - 12 month(s) ago
FDA and CDC have made yet another questionable decision
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 13
New asymptomatic cases discovered among close contacts of initial patient in city of Safed; Health Ministry warns of potential spread
Source: www.timesofisrael.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 3Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study - 1 year(s) ago
Objectives Although COVID-19 vaccines offer protection against infection and severe disease, there is limited information on the effect of vaccination on prolonged symptoms following COVID-19. Our objective was to determine differences in prevalence of prolonged symptoms 6 weeks after onset of COVID-19 among healthcare personnel (HCP) by vaccination status, and to assess differences in timing of…
Source: BMJ OpenCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Beth Linas (she/her), MHS, PhD (@bethlinas@med-mastodon.com) - 1 year(s) ago
As some have already noted there is a worrisome #measles outbreak happening in OH. Most if not all cases are in #unvaccinated children. WHY? How has #publichealth failed this much? (I know I know there isn’t much to be done about anti-vax folks but come on!) https://www.cnn.com/2022/11/17/health/measles-outbreak-columbus-ohio
Source: Med-MastodonCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5
But hospitalizations among the vaccinated are on the rise
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus - 2 year(s) ago
Objectives Numerous case reports have referred to new onset or flare of SLE after SARS-CoV-2 messenger RNA (mRNA) vaccines. Several observational studies showed that the short-term flare rate of SLE after SARS-CoV-2 vaccination is low. However, well-controlled clinical surveys are unavailable and the medium-term impact of the SARS-CoV-2 mRNA vaccines against the flare of SLE is uncertain….
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
But hospitalizations among the vaccinated are on the rise
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus - 2 year(s) ago
Objectives Numerous case reports have referred to new onset or flare of SLE after SARS-CoV-2 messenger RNA (mRNA) vaccines. Several observational studies showed that the short-term flare rate of SLE after SARS-CoV-2 vaccination is low. However, well-controlled clinical surveys are unavailable and the medium-term impact of the SARS-CoV-2 mRNA vaccines against the flare of SLE is uncertain….
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus - 2 year(s) ago
Objectives Numerous case reports have referred to new onset or flare of SLE after SARS-CoV-2 messenger RNA (mRNA) vaccines. Several observational studies showed that the short-term flare rate of SLE after SARS-CoV-2 vaccination is low. However, well-controlled clinical surveys are unavailable and the medium-term impact of the SARS-CoV-2 mRNA vaccines against the flare of SLE is uncertain….
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus - 2 year(s) ago
Objectives Numerous case reports have referred to new onset or flare of SLE after SARS-CoV-2 messenger RNA (mRNA) vaccines. Several observational studies showed that the short-term flare rate of SLE after SARS-CoV-2 vaccination is low. However, well-controlled clinical surveys are unavailable and the medium-term impact of the SARS-CoV-2 mRNA vaccines against the flare of SLE is uncertain….
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
The @US_FDA and @CDCgov recently announced that previously #unvaccinated Americans can now receive only a single dose of the bivalent Moderna or Pfizer mRNA #vaccines. In a recent #OpEd, John. P. Moore, PhD, calls this a "questionable decision." https://t.co/bH87UGdD3g